We are live on
!
Find out more
CC
Caxton Corporation Portfolio holdings
AUM
$4.02M
1-Year Est. Return
256.08%
This Fund
S&P 500
This Quarter
Est. Return
-41.88%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$118M
AUM Growth
–
Cap. Flow
+$176M
Cap. Flow
% of AUM
149.15%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
2
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$176M |
| 2 |
HALL
Hallmark Financial Services, Inc.
HALL
|
+$252K |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.78% |
| 2 | Financials | 0.22% |
Similar funds
PCM
EAMS
RCP
RA
CGA
HFA
ABA
UOMF
Caxton Corporation's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Caxton Corporation, which disclosed 2 positions worth $118M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Madrigal Pharmaceuticals: 675,196 shares worth $118M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, followed by Financials.
- Caxton Corporation's largest Q2 2013 buy was Madrigal Pharmaceuticals: 675,196 shares worth $118M.
- Caxton Corporation's ten largest holdings make up 100% of its $118M portfolio in Q2 2013.
- Caxton Corporation disclosed 2 positions in Q2 2013, its first 13F filing on record.
Based on Caxton Corporation's 13F filing for Q2 2013, filed 14 Aug 2013.